An open-label study to assess the feasibility and tolerability of rilmenidine for the treatment of Huntington's disease.
about
An open-label study to assess the feasibility and tolerability of rilmenidine for the treatment of Huntington's disease.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
An open-label study to assess ...... tment of Huntington's disease.
@en
An open-label study to assess ...... tment of Huntington's disease.
@nl
type
label
An open-label study to assess ...... tment of Huntington's disease.
@en
An open-label study to assess ...... tment of Huntington's disease.
@nl
prefLabel
An open-label study to assess ...... tment of Huntington's disease.
@en
An open-label study to assess ...... tment of Huntington's disease.
@nl
P2093
P2860
P1433
P1476
An open-label study to assess ...... tment of Huntington's disease.
@en
P2093
Benjamin R Underwood
David C Rubinsztein
Jules Griffin
P Simon Jones
Peter J Pugh
Sarah L Mason
Stanley E Lazic
Zeyn W Green-Thompson
P2860
P2888
P304
P356
10.1007/S00415-017-8647-0
P577
2017-10-26T00:00:00Z